Skip to main content

Exact Sciences Inks $25.6M and $15M Loan Agreements

NEW YORK (GenomeWeb) – Exact Sciences said in a document filed with the US Securities and Exchange Commission today that it has inked revolving and non-revolving loan agreements with MB Financial Bank.

The revolving loan agreement provides Exact Sciences with a 24-month secured revolving credit facility of up to $15.0 million with a Dec. 10, 2019 maturity date.

Amounts borrowed under the revolving loan agreement accrue interest at one of three yearly rates elected by Exact Sciences. They are the sum of the one-month Libor rate plus 2 percent; the sum of the three-month Libor rate plus 2 percent; and the MB Bank Reference Rate minus .5 percent.

The firm noted that it anticipates using the loan to fund facility renovation, development and construction projects, and other general working-capital activities.

The non-revolving construction loan agreement inked by Exact Sciences subsidiary GC Growth with MB Bank provides up to $25.6 million with a maturity date of Dec. 10, 2022. The agreement bears interest at a rate equal to the sum of the one-month Libor rate plus 2.25 percent.

Exact said in the SEC document that it expects to use that loan to finance the construction of a clinical laboratory and related facilities, and to conduct additional development of a 46-acre campus in Madison, Wisconsin. As a condition of the agreement, Exact is required to invest at least $16.4 million of its cash in the construction project. 

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.